BiondVax to Provide Update of M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial at IVW2019 Conference

Stock Information for Scinai Immunotherapeutics Ltd Sponsed ADR (New)

Loading

Please wait while we load your information from QuoteMedia.